September 25, 2017 10:01 PM ET

Biotechnology

Company Overview of QIAGEN, Inc.

Company Overview

QIAGEN, Inc. operates as a biotechnology company that offers technologies and products for separating and purifying nucleic acids. The company's technologies include Anion-exchange and silica gel–membrane technologies, Lysate filtration technologies, High-throughput and automation formats, and Columns and multiwell modules. The company develops and markets products for academic and industrial markets, scientific research, genomics, gene-based drug discovery, nucleic acid-based molecular diagnostics, genetic vaccination, and gene therapy markets. The company was founded in 1988 and is based in Valencia, California. QIAGEN, Inc. operates as a subsidiary of QIAGEN N.V.

27220 Turnberry Lane

Suite 200

Valencia, CA 91355

United States

Founded in 1988

Phone:

800-426-8157

Fax:

800-718-2056

Key Executives for QIAGEN, Inc.

Associate Director of R&D
Director of IT
Compensation as of Fiscal Year 2017.

QIAGEN, Inc. Key Developments

QIAGEN, Inc. Presents at Biodefence World Summit 2017, Jun-28-2017 02:15 PM

QIAGEN, Inc. Presents at Biodefence World Summit 2017, Jun-28-2017 02:15 PM. Venue: Westin Alexandria, 400 Courthouse Square, Alexandria, VA 22314, Virginia, United States. Speakers: Roberto Spricigo, OEM Manager, Point-of-Need.

Oxford Immunotec Global plc Announces Favorable Recommendation by the Magistrate Judge in Patent Infringement Litigation Against Qiagen, Inc., Quest Diagnostics, Inc. and Laboratory Corporation of America Holdings

Oxford Immunotec Global PLC announced that the U.S. Magistrate Judge in the company’s patent infringement lawsuit against Qiagen, Inc., Quest Diagnostics, Inc. and Laboratory Corporation of America Holdings has issued a recommendation denying in substantial part the defendants’ motion to dismiss the company’s claims. The magistrate judge’s recommendation should now allow the company to press forward with its case against the three defendants, asserting infringement of its six patents relating to methods for diagnosing TB infection.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
Bertelsmann AG Europe

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact QIAGEN, Inc., please visit www.qiagen.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.